Actinium Pharmaceuticals, Inc. - ATNM
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Chief Financial Officer | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Oct 16, 2026 | Chief Financial Officer | A | A | 250,000.0 | 0.0 | 0.0 | 250,000.0 | View | |
| Sep 04, 2026 | — | A | A | 92,400.0 | 0.0 | 0.0 | 92,400.0 | View | |
| Sep 04, 2026 | — | A | A | 61,600.0 | 0.0 | 0.0 | 62,357.0 | View | |
| Sep 04, 2026 | — | A | A | 94,200.0 | 0.0 | 0.0 | 94,200.0 | View | |
| Sep 04, 2026 | — | A | A | 62,800.0 | 0.0 | 0.0 | 63,300.0 | View | |
| Sep 04, 2026 | — | A | A | 27,000.0 | 0.0 | 0.0 | 27,000.0 | View | |
| Sep 04, 2026 | — | A | A | 18,000.0 | 0.0 | 0.0 | 18,000.0 | View | |
| Sep 04, 2026 | Chief Executive Officer | A | A | 1,130,400.0 | 0.0 | 0.0 | 1,130,400.0 | View | |
| Sep 04, 2026 | Chief Executive Officer | A | A | 1,027,274.0 | 0.0 | 0.0 | 1,965,355.0 | View | |
| Sep 04, 2026 | Chief Executive Officer | A | A | 753,600.0 | 0.0 | 0.0 | 938,081.0 | View | |
| Sep 04, 2026 | — | A | A | 94,200.0 | 0.0 | 0.0 | 94,200.0 | View | |
| Sep 04, 2026 | — | A | A | 62,800.0 | 0.0 | 0.0 | 63,116.0 | View | |
| Sep 04, 2026 | — | A | A | 92,400.0 | 0.0 | 0.0 | 92,400.0 | View | |
| Sep 04, 2026 | — | A | A | 61,600.0 | 0.0 | 0.0 | 61,600.0 | View |